Hologic (HOLX) Tops Q2 EPS by 2c; Guides Q3 Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Hologic Announces Financial Results for Second Quarter of Fiscal 2021
April 28, 2021 4:01 PM EDT-- Revenue of $1.538 Billion Increases 103.4%, 98.7% in Constant Currency --
-- Organic Revenue Increases 104.7%, 100.0% in Constant Currency --
-- Company Posts GAAP Diluted EPS of $2.38, Non-GAAP Diluted EPS of $2.59 --
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Companys financial results for the fiscal second quarter ended March 27, 2021.
Hologic posted very strong financial results in our second fiscal quarter in line with our guidance, said Steve MacMillan, the Companys chairman, president and chief executive officer. Organic... More
